×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PLSE – pulse biosciences, inc (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PLSE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/19
04:05 pm
plse
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/19
12:40 pm
plse
PLSE Wins FDA IDE Approval to Launch nPulse AF Ablation Study Trial [Yahoo! Finance]
Low
Report
PLSE Wins FDA IDE Approval to Launch nPulse AF Ablation Study Trial [Yahoo! Finance]
12/18
07:40 am
plse
Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation [Yahoo! Finance]
Low
Report
Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation [Yahoo! Finance]
12/18
07:00 am
plse
Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation
Low
Report
Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation
12/9
07:00 am
plse
Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse™ Technology
Low
Report
Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse™ Technology
11/21
04:05 pm
plse
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/6
04:05 pm
plse
Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
Low
Report
Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
11/6
12:10 am
plse
Pulse Biosciences Inc (PLSE) Q3 2025 Earnings Call Highlights: Regulatory Milestones and Early ... [Yahoo! Finance]
Medium
Report
Pulse Biosciences Inc (PLSE) Q3 2025 Earnings Call Highlights: Regulatory Milestones and Early ... [Yahoo! Finance]
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/18
09:00 am
plse
Form 8-K PULSE BIOSCIENCES, INC. For: Dec 18
Low
Report
Form 8-K PULSE BIOSCIENCES, INC. For: Dec 18
12/12
04:04 pm
plse
Form 8-K PULSE BIOSCIENCES, INC. For: Dec 09
Low
Report
Form 8-K PULSE BIOSCIENCES, INC. For: Dec 09
12/9
04:04 pm
plse
Form 8-K PULSE BIOSCIENCES, INC. For: Dec 09
Medium
Report
Form 8-K PULSE BIOSCIENCES, INC. For: Dec 09
11/13
09:29 am
plse
Form 8-K PULSE BIOSCIENCES, INC. For: Nov 13
Medium
Report
Form 8-K PULSE BIOSCIENCES, INC. For: Nov 13
11/5
04:17 pm
plse
Form 10-Q PULSE BIOSCIENCES, INC. For: Sep 30
Medium
Report
Form 10-Q PULSE BIOSCIENCES, INC. For: Sep 30
11/5
04:12 pm
plse
Form 8-K PULSE BIOSCIENCES, INC. For: Nov 05
Medium
Report
Form 8-K PULSE BIOSCIENCES, INC. For: Nov 05
10/28
10:19 am
plse
Form DEF 14A PULSE BIOSCIENCES, INC. For: Dec 09
Low
Report
Form DEF 14A PULSE BIOSCIENCES, INC. For: Dec 09
10/28
06:03 am
plse
Form DEFA14A PULSE BIOSCIENCES, INC.
Low
Report
Form DEFA14A PULSE BIOSCIENCES, INC.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/16
Pulse Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results
33.7%
4/6 Form S-3 Pulse Biosciences, Inc. 11.5%
4/29 Pulse Biosciences Schedules First Quarter 2020 Financial Results Conference Call for May 11, 2020 7.8%
9/10 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.5%
3/31 Form 10-K/A Pulse Biosciences, Inc. For: Dec 31 6.7%
4/14 Form S-3/A Pulse Biosciences, Inc. 5.9%
2/11 Pulse Biosciences Inc (NASDAQ: PLSE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 5.4%
4/21 Form S-3/A Pulse Biosciences, Inc. 5.0%
12/19 Form 8-K Pulse Biosciences, Inc. For: Dec 19 4.8%
9/4 Pulse Biosciences Grants Equity Incentive Awards to New Employees 4.2%
4/6 Form S-3 Pulse Biosciences, Inc. 11.5%
4/29 Pulse Biosciences Schedules First Quarter 2020 Financial Results Conference Call for May 11, 2020 7.8%
9/10 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.5%
3/31 Form 10-K/A Pulse Biosciences, Inc. For: Dec 31 6.7%
4/14 Form S-3/A Pulse Biosciences, Inc. 5.9%
2/11 Pulse Biosciences Inc (NASDAQ: PLSE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 5.4%
4/21 Form S-3/A Pulse Biosciences, Inc. 5.0%
12/19 Form 8-K Pulse Biosciences, Inc. For: Dec 19 4.8%
9/4 Pulse Biosciences Grants Equity Incentive Awards to New Employees 4.2%
TOP News Decliners
2/13
Pulse Biosciences Provides Update on FDA 510(k) Submission for the CellFX System in Dermatology
-29.8%
5/1 Form S-3/A Pulse Biosciences, Inc. -23.4%
3/17 Pulse Biosciences Grants Equity Incentive Awards to New Employees -10.3%
4/14 Form DEF 14A Pulse Biosciences, Inc. For: Apr 14 -7.8%
8/8 Form 10-Q Pulse Biosciences, Inc. For: Jun 30 -6.9%
12/18 Pulse Biosciences Updates on Regulatory Progress -5.4%
11/19 Form 3 Pulse Biosciences, Inc. For: Nov 18 Filed by: GARDINER SANDRA A. -4.9%
3/12 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating. -4.4%
5/17 Form 8-K Pulse Biosciences, Inc. For: May 16 -4.4%
9/26 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -4.2%
5/1 Form S-3/A Pulse Biosciences, Inc. -23.4%
3/17 Pulse Biosciences Grants Equity Incentive Awards to New Employees -10.3%
4/14 Form DEF 14A Pulse Biosciences, Inc. For: Apr 14 -7.8%
8/8 Form 10-Q Pulse Biosciences, Inc. For: Jun 30 -6.9%
12/18 Pulse Biosciences Updates on Regulatory Progress -5.4%
11/19 Form 3 Pulse Biosciences, Inc. For: Nov 18 Filed by: GARDINER SANDRA A. -4.9%
3/12 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating. -4.4%
5/17 Form 8-K Pulse Biosciences, Inc. For: May 16 -4.4%
9/26 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -4.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: